Fiera Capital Corp Incyte Corp Transaction History

Fiera Capital Corp

$31.6 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Aug 22, 2024	BUY	$56.55 - $66.59 $200,752 - $236,394	3,550 New	3,550 $202,000
Q1 2024 May 01, 2024	BUY	$56.55 - $66.59 $18,378 - $21,641	325 Added 10.08%	3,550 $202,000
Q4 2023 Aug 22, 2024	BUY	$52.16 - $64.19 $168,216 - $207,012	3,225 New	3,225 $202,000
Q4 2023 Feb 08, 2024	BUY	$52.16 - $64.19 $168,216 - $207,012	3,225 New	3,225 $202,000
Q1 2023 Apr 26, 2023	BUY	$70.23 - $86.01 $142,215 - $174,170	2,025 Added 34.82%	7,840 $566,000
Q4 2022 Feb 08, 2023	SELL	$67.18 - $84.11 $47,026 - $58,877	-700 Reduced 10.74%	5,815 $467,000
Q3 2022 Nov 03, 2022	SELL	$66.18 - $82.86 $266,374 - $333,511	-4,025 Reduced 38.19%	6,515 $434,000
Q2 2022 Aug 10, 2022	SELL	$66.18 - $83.18 $2.14 Million - $2.69 Million	-32,325 Reduced 75.41%	10,540 $801,000
Q1 2022 May 09, 2022	BUY	$66.02 - $79.71 $2.24 Million - $2.71 Million	33,965 Added 381.63%	42,865 $3.4 Million
Q4 2021 Feb 08, 2022	BUY	$63.34 - $74.11 $84,558 - $98,936	1,335 Added 17.65%	8,900 $653,000
Q2 2021 Aug 11, 2021	SELL	$79.87 - $87.53 $2.02 Million - $2.21 Million	-25,260 Reduced 76.95%	7,565 $787,000
Q1 2021 May 11, 2021	SELL	$76.02 - $100.5 $711,471 - $940,579	-9,359 Reduced 22.19%	32,825 $2.67 Million
Q4 2020 Feb 09, 2021	BUY	$80.74 - $97.7 $2.2 Million - $2.67 Million	27,299 Added 183.4%	42,184 $3.67 Million
Q3 2020 Nov 12, 2020	SELL	$85.07 - $109.69 $40,918 - $52,760	-481 Reduced 3.13%	14,885 $1.34 Million
Q2 2020 Aug 07, 2020	BUY	$74.18 - $108.93 $296,794 - $435,828	4,001 Added 35.2%	15,366 $1.6 Million
Q1 2020 May 08, 2020	SELL	$63.18 - $85.97 $97,044 - $132,049	-1,536 Reduced 11.91%	11,365 $832,000
Q4 2019 Feb 06, 2020	BUY	$73.04 - $95.72 $942,289 - $1.23 Million	12,901 New	12,901 $1.13 Million

Others Institutions Holding INCY

# of Institutions

644

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.6B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Fiera Capital Corp with notifications on news.

Account